Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Available NCT05619367

A Compassionate Use (CU) Program of Odronextamab

Conditions: Relapsed or Refractory (R/R) Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Non-Hodgkin Lymphoma (NHL), High-Grade B-Cell Lymphoma (HGBCL)

Sex: All
Sponsor: Regeneron Pharmaceuticals

Summary

Provide compassionate use of odronextamab

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05619367). StuddyBuddy aggregates publicly available trial information.